Sheng Xue Ning as a Novel Agent that Promotes SCF-Driven Hematopoietic Stem/Progenitor Cell Proliferation to Promote Erythropoiesis
Biomolecules · 2024
DOI: 10.3390/biom14091147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Yueying Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University,…. Hauptthemen laut MEDLINE: Erythropoiesis, Hematopoietic Stem Cells, Stem Cell Factor, Cell Proliferation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science Foundation of China, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Stimulating erythropoiesis is essential in the treatment of various types of anemia. Sheng Xue Ning (SXN) is commonly used in China as an iron supplement to treat iron deficiency anemia, renal anemia, and anemia in pregnancy. This research reports a novel effect of SXN in enhancing the proliferation of hematopoietic stem/progenitor cell (HSPC) to promote erythropoiesis in the bone marrow, which is distinct from conventional iron supplements that primarily aid in the maturation of red blood cells. Employing a model of hematopoietic dysfunction induced by X-ray exposure, we evaluated the efficacy of SXN in restoring hematopoietic function. SXN significantly promoted the recovery of peripheral erythroid cells and enhanced the proliferation and differentiation of Lin−/c-KIT+/Sca-1+ HSPC in mice exposed to X-ray irradiation. Our results showed that SXN elevated the expression of stem cell factor (SCF) and activated the SCF/c-KIT/PI3K/AKT signaling pathway, facilitating the proliferation and differentiation of HSPC. In vitro, SXN markedly enhanced the proliferation of bone marrow nucleated cell (BMNC) and the colony-forming capacity of BFU-E, CFU-E, and CFU-GM, while also elevating the expression of proteins involved in the SCF/c-KIT/PI3K/AKT pathway in BMNC. Additionally, SXN enhanced the proliferation and differentiation of mesenchymal stem cell (MSC) and increased SCF secretion. In conclusion, SXN demonstrates the capacity to enhance erythropoiesis by upregulating SCF expression, thereby promoting HSPC proliferation and differentiation via the SCF/c-KIT/PI3K/AKT pathway. SXN may offer a new strategy for improving the activity of HSPC and promoting erythropoiesis in the treatment of hematopoiesis disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
- School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.
ORCID-Profile: Anguo Wu, Wenjun Zou, Jianming Wu, Feihong Huang
Förderung
- National Natural Science Foundation of China
- National Science Foundation of China
- Sichuan Science and Technology Program
- Science and Technology Planning Project of Luzhou, Sichuan Province, China
- Science and Technology Planning Project of Southwest Medical University, Sichuan Province, China
Zitieren
APA
Zeng, Y., Li, C., Yang, F., Zhang, L., Xu, W., Wang, L., Wu, A., Zou, W., Wu, J., & Huang, F. (2024). Sheng Xue Ning as a Novel Agent that Promotes SCF-Driven Hematopoietic Stem/Progenitor Cell Proliferation to Promote Erythropoiesis. Biomolecules. https://doi.org/10.3390/biom14091147
Vancouver
Zeng Y, Li C, Yang F, Zhang L, Xu W, Wang L, et al. Sheng Xue Ning as a Novel Agent that Promotes SCF-Driven Hematopoietic Stem/Progenitor Cell Proliferation to Promote Erythropoiesis. Biomolecules. 2024. doi:10.3390/biom14091147
BibTeX
@article{Zeng2024,
author = {Zeng, Yueying and Li, Chunlu and Yang, Fei and Zhang, Ling and Xu, Wanqi and Wang, Long and Wu, Anguo and Zou, Wenjun and Wu, Jianming and Huang, Feihong},
title = {Sheng Xue Ning as a Novel Agent that Promotes SCF-Driven Hematopoietic Stem/Progenitor Cell Proliferation to Promote Erythropoiesis},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14091147}
}
EUVIMED